Saturday, Juli 2, 9.00 Kleiner Hörsaal Chirurgie Workgroup Meetings on NET, Thyroid Cancer and Prostate Cancer – Re/Defining Institutional Guidelines Work-Group Meeting: „FDG in NET – Defining a Guideline“ Moderation: I. Virgolini, L. Kabasakal, J. Cwikla, A. Versari, P. Muto, V. Prasad, C. Decristoforo, M. Rodrigues, F. Ceci, A. Haug, M. Gabriel Work-Group Meeting: „Thyroid Cancer – Management of Thyroid Cancer, Review of Guidelines“ Moderation: R. Moncayo, T. Theurl, R. Prommegger, M. Farsad, R. Madleitner, M. Jeller, W. Zechmann, V. Kenjic Work-Group Meeting: „Theragnostics of Non-NETs-Defining an Institutional Guideline on Theragnostics“ Moderation: A. Kroiss, B. Nilica, E. Guggenberg, L. Geraldo, V. Kenjic, C. Mair, A. Wurzer, C. Rangger, B. Trackner, C. Decristoforo Work-Group Meeting: „Prostate Cancer – Defining an Institutional Guideline on Theragnostics“ Moderation: W. Horninger, J. Bektic, C. Uprimny, S. Buxbaum, S. Dizdarevic, L. Scarpa, B., G. Di Santo, B. Neururer, A. Hutter L. Geraldo 13.00-14.00 Lunch Break 17.00-18.30 Presentation of Re/Defined Guidelines by Moderators, (Location to be announced) 19.30-23.30 Society Evening & Scientific Discussion Wir bedanken uns für die großzügige Unterstützung bei: Bayer HealthCare, BSM Diagnostica, GE Healthcare, Hermes Medical Solutions, IASON, IPSEN Pharma, ITG Isotope Technologies Garching, Novartis Oncology, Genzyme, Siemens Healthcare, THP Medical Products Akkreditierung durch die Tiroler Ärztekammer: 6 DFP NUK Anmeldung bitte unter: [email protected] Landeskrankenhaus - Universitätskliniken - Innsbruck Universitätsklinik für Nuklearmedizin Anichstrasse 35, A-6020 Innsbruck Direktor: Univ.-Prof. Dr. Irene J. Virgolini Tel.: +43-512-504/22651, Fax: +43-512-504/22659 www.nuklearmedizin-innsbruck.com I N V I T A T I O N E I N L A D U N G 11. Tiroler Nuklearmedizin Kongress July 1- 2, 2016 Großer Hörsaal Chirurgie „THERAGNOSTICS“ - STATUS 2016 Wir bedanken uns für die gute Zusammenarbeit bei unseren Kooperationspartnern und für das Vertrauen bei unseren Zuweisern! Irene Virgolini und das Team der Univ.-Klinik für Nuklearmedizin Friday, Juli 1, 13.00 Welcome and Opening Remarks Irene Virgolini Symposium 1:THERAGNOSTICS OF NET Chair: G. Gastl, P. Muto 13.15 Llanos Geraldo Roig, Innsbruck Current Status of SSTR-targeted Diagnosis at Innsbruck 13.30 Bernhard Nilica, Innsbruck Current Status of SSTR-targeted Therapy at Innsbruck 13.45 Stefano Fanti & Franceso Ceci, Bologna Current Status of SSTR-targeted Theragnostics at Bologna 14.00 Mohsen Farsad, Bozen Current Status of SSTR-targeted Theragnostics at Bozen 14.15 Levent Kabasakal, Istanbul Overview of SSTR- targeted Theragnostics at Istanbul 14.30 Alexander Haug, Vienna Overview of SSTR- targeted Theragnostics at Vienna 14.45 Annibale Versari, Reggio di Emilia Overview of SSTR-targeted Theragnostics at Reggio de Emilia 15.00 Jaroslaw Cwikla, Poland Overview of SSTR- targeted Theragnostics at Warsaw 15.15 Vikas Prasad, Berlin Overview of SSTR- targeted Theragnostics at Berlin/BadBerka 15.30 – 16.00 Coffee Break und Industrieausstellung Kleiner Hörsaal Chirurgie Symposium 2: THERAGNOSTICS OF PROSTATE CANCER Chair: W. Horninger, P. Lukas 16.00 Christian Uprimny, Innsbruck Current Status of 68Ga-PSMA-targeted Diagnosis at Innsbruck 16.15 Lorenza Scarpa, Innsbruck Current Status of PSMA-targeted Therapy at Innsbruck 16.30 Stefano Fanti, Francesco Ceci, Bologna Current Status of Theragnostics at Bologna 16.45 Mohsen Farsad, Bozen Current Status of Theragnostics at Bozen 17.00 Levent Kabasakal, Istanbul Current Status of Theragnostics at Istanbul 17.15 Alexander Haug, Vienna Current Status of Theragnostics at Vienna 17.30 Sabina Dizdarevic, UK Results of Radium-223 dichloride at Sutton 17.45 Sabine Buxbaum, Innsbruck Results of Radium-223 dichloride at Innsbruck 18.00 Michael Gabriel, Linz Presentation of first results of Radium-223 dichloride at Linz 19.30 - 23.30 Society Evening & Scientific Discussion Restaurant Fischerhäusl, Herrengasse 8, Innsbruck
© Copyright 2024 ExpyDoc
